Corbus Pharmaceuticals: 3Q Earnings Snapshot
NORWOOD, Mass. (AP) _ Corbus Pharmaceuticals Holdings Inc. (CRBP) on Thursday reported a loss of $14.6 million in its third quarter.
The Norwood, Massachusetts-based company said it had a loss of 26 cents per share.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 21 cents per share.
The drug developer posted revenue of $1.1 million in the period, which also fell short of Street forecasts. Three analysts surveyed by Zacks expected $1.7 million.
Corbus Pharmaceuticals shares have increased roughly 4 percent since the beginning of the year. The stock has climbed slightly more than 7 percent in the last 12 months.